Robert Moussa

Track

Insider profile

Performance

Overall performance
1.3
Performance over holding periods
1.3
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Derma Sciences Inc May 1, 2005 - Feb. 24, 2017
Independent Director Calmare Therapeutics Inc Jan. 23, 2012 - Oct. 15, 2015
Robert Moussa's trades of Daxor Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Daxor Corp (DXR)
Transaction date
Purchase
Price
35.89
Quantity 12,054 -48.3%
Value US$4,002,250
US Daxor Corp (DXR)
Transaction date
Purchase
Price
273.40
Quantity 49,159 +31.5%
Value US$4,901,405
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2006-10-31 2006-10-31
US Daxor Corp (DXR)
B Purchase
12,054 -48.3%
35.89
US$4,002,250 		12,054 -48.3% 35.89 US$4,002,250
2006-06-20 2006-06-16
US Daxor Corp (DXR)
B Purchase
49,159 +31.5%
273.40
US$4,901,405 		49,159 +31.5% 273.40 US$4,901,405